Lieberman J M, Marks W H, Cohn S, Jaicks R, Woode L, Sacchettini J, Fischer B, Moller B, Burns G
Department of Organ Transplantation, Swedish Medical Center, Seattle, Washington, USA.
J Trauma. 1998 Nov;45(5):900-6. doi: 10.1097/00005373-199811000-00011.
Intestinal mucosal ischemia and subsequent barrier dysfunction have been related to the development of organ dysfunction and death in the critically ill. We hypothesized that urine concentrations of intestinal fatty acid binding protein (IFABP), a sensitive marker of intestinal ischemia, might predict the development of the systemic inflammatory response syndrome (SIRS) and organ dysfunction.
One hundred consecutive critically ill patients were prospectively studied for the development of infectious complications, organ dysfunction, and SIRS. Urine was collected daily for measurement of IFABP.
A total of 58 males and 42 females (mean age, 56 years; range,16-85 years) were studied. Of these 100 patients, 40 patients developed complications and 5 patients developed SIRS. IFABP was significantly elevated in all patients with SIRS, and IFABP levels peaked an average of 1.4 days (range, 0-7 days) before the diagnosis of SIRS.
Elevated concentrations of urine IFABP correlated with the clinical development of SIRS. Studies to assess the utility of IFABP as a predictor of organ dysfunction and SIRS in the critically ill are warranted.
肠黏膜缺血及随后的屏障功能障碍与危重症患者器官功能障碍及死亡的发生有关。我们推测,肠道脂肪酸结合蛋白(IFABP)是肠道缺血的敏感标志物,其尿浓度可能预测全身炎症反应综合征(SIRS)及器官功能障碍的发生。
对连续100例危重症患者进行前瞻性研究,观察感染性并发症、器官功能障碍及SIRS的发生情况。每天收集尿液以测定IFABP。
共研究了58例男性和42例女性患者(平均年龄56岁;范围16 - 85岁)。在这100例患者中,40例发生并发症,5例发生SIRS。所有SIRS患者的IFABP均显著升高,且IFABP水平在SIRS诊断前平均1.4天(范围0 - 7天)达到峰值。
尿IFABP浓度升高与SIRS的临床发生相关。有必要开展研究评估IFABP作为危重症患者器官功能障碍和SIRS预测指标的效用。